Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion type Assertion NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_head.
- NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion description "[However, simultaneous blockade of p110? and ErbB RTKs results in superior inhibition of PI3K and mammary tumor growth, suggesting a rational therapeutic combination against breast cancers harboring PIK3CA activating mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_provenance.
- NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion evidence source_evidence_literature NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_provenance.
- NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion SIO_000772 23633485 NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_provenance.
- NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion wasDerivedFrom befree-2016 NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_provenance.
- NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_assertion wasGeneratedBy ECO_0000203 NP1073861.RAsk4XOVZtjC5F5OoN4FRbyQ5Ka3c0v3aAuOgu0r9rTNg130_provenance.